Pfizer Says Sutent Fails In Breast Cancer Studies CBS News "Sunitinib (Sutent) has been thoroughly evaluated in advanced HER-2 negative breast cancer, and while we are disappointed in the results, these trials have ...
Variable Blood Pressure a New Stroke Risk Factor? Palm Beach Post A meta-analysis of 389 controlled trials found that effects on blood pressure variability explained why some classes of blood pressure drugs were more ...
Pfizer ends study on potential lung cancer drug San Diego Union Tribune The company plans on continuing to study the drug candidate in clinical trials focusing on prostate, breast, and other cancers, including types of lung ...
Pfizer says Sutent fails in breast cancer studies Marin Independent-Journal "Sunitinib (Sutent) has been thoroughly evaluated in advanced HER-2 negative breast cancer, and while we are disappointed in the results, these trials have ...
Pfizer says Sutent fails in breast cancer studies Bioscience Technology "Sunitinib (Sutent) has been thoroughly evaluated in advanced HER-2 negative breast cancer, and while we are disappointed in the results, these trials have ...
Pfizer ends study on potential lung cancer drug Monterey County Herald The company plans on continuing to study the drug candidate in clinical trials focusing on prostate, breast, and other cancers, including types of lung ...
Pfizer says Sutent fails in breast cancer studies KAALtv.com "Sunitinib (Sutent) has been thoroughly evaluated in advanced HER-2 negative breast cancer, and while we are disappointed in the results, these trials have ...
Pfizer ends study on potential lung cancer drug Tuscaloosa News (subscription) The company plans on continuing to study the drug candidate in clinical trials focusing on prostate, breast, and other cancers, including types of lung ...
Pfizer says Sutent fails in breast cancer studies KTVZ "Sunitinib (Sutent) has been thoroughly evaluated in advanced HER-2 negative breast cancer, and while we are disappointed in the results, these trials have ...
Pfizer ends study on potential lung cancer drug Pharmaceutical Processing The company plans on continuing to study the drug candidate in clinical trials focusing on prostate, breast, and other cancers, including types of lung ...